72 related articles for article (PubMed ID: 36633800)
1. Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis.
Mayo ZS; Halima A; Broughman JR; Smile TD; Tom MC; Murphy ES; Suh JH; Lo SS; Barnett GH; Wu G; Johnson S; Chao ST
J Neurooncol; 2023 Jan; 161(1):23-31. PubMed ID: 36633800
[TBL] [Abstract][Full Text] [Related]
2. Use of 18 F-PSMA PET to Distinguish Cerebral Radiation Necrosis From Tumor Recurrence.
Rayamajhi SJ; Ponisio MR; Siegel B
Clin Nucl Med; 2023 Oct; 48(10):e483-e484. PubMed ID: 37486317
[TBL] [Abstract][Full Text] [Related]
3. Delayed Imaging Changes 18 Months or Longer After Stereotactic Radiosurgery for Brain Metastases: Necrosis or Progression.
Williams MM; Sohrabi AK; Kittel CA; White JJ; Cramer CK; Lanier CM; Ruiz J; Xing F; Li W; Whitlow CT; Tatter SB; Chan MD; Laxton AW
World Neurosurg; 2024 Jan; 181():e453-e458. PubMed ID: 37865197
[TBL] [Abstract][Full Text] [Related]
4.
Tom MC; DiFilippo FP; Jones SE; Suh JH; Obuchowski NA; Smile TD; Murphy ES; Yu JS; Barnett GH; Angelov L; Mohammadi AM; Huang SS; Wu G; Johnson S; Peereboom DM; Stevens GHJ; Ahluwalia MS; Chao ST
J Neurooncol; 2023 Jul; 163(3):647-655. PubMed ID: 37341842
[TBL] [Abstract][Full Text] [Related]
5. Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression and radionecrosis.
Dagher R; Gad M; da Silva de Santana P; Sadeghi MA; Yewedalsew SF; Gujar SK; Yedavalli V; Köhler CA; Khan M; Tavora DGF; Kamson DO; Sair HI; Luna LP
J Neurooncol; 2024 Jan; 166(1):1-15. PubMed ID: 38212574
[TBL] [Abstract][Full Text] [Related]
6. Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X).
Dobeson CB; Birkbeck M; Bhatnagar P; Hall J; Pearson R; West S; English P; Butteriss D; Perthen J; Lewis J
Br J Radiol; 2023 Dec; 96(1152):20220462. PubMed ID: 37660364
[TBL] [Abstract][Full Text] [Related]
7. Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment.
Weinberg BD; Kuruva M; Shim H; Mullins ME
Radiol Clin North Am; 2021 May; 59(3):349-362. PubMed ID: 33926682
[TBL] [Abstract][Full Text] [Related]
8. Selective Cell Size MRI Differentiates Brain Tumors from Radiation Necrosis.
Devan SP; Jiang X; Luo G; Xie J; Quirk JD; Engelbach JA; Harmsen H; McKinley ET; Cui J; Zu Z; Attia A; Garbow JR; Gore JC; McKnight CD; Kirschner AN; Xu J
Cancer Res; 2022 Oct; 82(19):3603-3613. PubMed ID: 35877201
[TBL] [Abstract][Full Text] [Related]
9. Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma.
Palmer JD; Perlow HK; Lehrer EJ; Wardak Z; Soliman H
Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S46-S55. PubMed ID: 38437668
[TBL] [Abstract][Full Text] [Related]
10. Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis.
Nichelli L; Casagranda S
Curr Opin Oncol; 2021 Nov; 33(6):597-607. PubMed ID: 34534142
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Efficacy of Perfusion MRI and Conventional MRI in Distinguishing Recurrent Cerebral Metastasis from Brain Radiation Necrosis.
Schack A; Aunan-Diop JS; Gerhardt FA; Pedersen CB; Halle B; Kofoed MS; Markovic L; Wirenfeldt M; Poulsen FR
Brain Sci; 2024 Mar; 14(4):. PubMed ID: 38671973
[TBL] [Abstract][Full Text] [Related]
12. Challenges in radiological evaluation of brain metastases, beyond progression.
Ortiz de Mendivil A; Martín-Medina P; García-Cañamaque L; Jiménez-Munarriz B; Ciérvide R; Diamantopoulos J
Radiologia (Engl Ed); 2024; 66(2):166-180. PubMed ID: 38614532
[TBL] [Abstract][Full Text] [Related]
13. Late post-treatment radiographic changes 3 years following chemoradiation for glioma: the importance of histopathology.
Galante JR; Rodriguez F; Grossman SA; Strowd RE
CNS Oncol; 2017 Jul; 6(3):195-201. PubMed ID: 28718307
[TBL] [Abstract][Full Text] [Related]
14. Editorial: Ano-rectal and gastro-esophageal cancer: diving into diagnostic and therapeutic imaging modalities for radiotherapy.
Deantonio L; De Bari B; Franco P
Front Oncol; 2023; 13():1276334. PubMed ID: 37719016
[No Abstract] [Full Text] [Related]
15. Radiation Necrosis Versus Tumor Progression: The Path Toward an Optimal Discriminator.
Delery W; Savjani RR
Radiol Imaging Cancer; 2023 Mar; 5(2):e239004. PubMed ID: 36897223
[No Abstract] [Full Text] [Related]
16. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
[TBL] [Abstract][Full Text] [Related]
17. Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities.
Smith EJ; Naik A; Shaffer A; Goel M; Krist DT; Liang E; Furey CG; Miller WK; Lawton MT; Barnett DH; Weis B; Rizk A; Smith RS; Hassaneen W
J Neurooncol; 2023 Mar; 162(1):15-23. PubMed ID: 36853489
[TBL] [Abstract][Full Text] [Related]
18. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
[TBL] [Abstract][Full Text] [Related]
19. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
